Predictive Oncology Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Predictive Oncology Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Predictive Oncology Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.2M, a 23.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.2M -$666K -23.2% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.43M -$576K -19.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.58M -$480K -15.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.6M +$2.39M +1126% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.87M +$2.54M +771% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.01M +$2.5M +495% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.06M +$2.41M +370% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $212K -$603K -74% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $330K -$632K -65.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $506K -$626K -55.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $652K -$578K -47% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $814K -$581K -41.6% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $961K -$829K -46.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.13M -$396K -25.9% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $1.23M +$598K +94.8% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $1.4M +$666K +91.2% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.79M +$903K +102% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $1.53M +$523K +52% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $631K +$297K +89.1% Mar 31, 2020 10-Q 2020-06-08
Q4 2019 $730K Dec 31, 2019 10-K 2021-03-15
Q3 2019 $887K Sep 30, 2019 10-Q 2019-11-15
Q2 2019 $1.01M Jun 30, 2019 10-Q 2019-08-19
Q1 2019 $334K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.